252 related articles for article (PubMed ID: 27476652)
1. GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.
Lim YH; Bacchiocchi A; Qiu J; Straub R; Bruckner A; Bercovitch L; Narayan D; ; McNiff J; Ko C; Robinson-Bostom L; Antaya R; Halaban R; Choate KA
Am J Hum Genet; 2016 Aug; 99(2):443-50. PubMed ID: 27476652
[TBL] [Abstract][Full Text] [Related]
2. High frequency of GNA14, GNAQ, and GNA11 mutations in cherry hemangioma: a histopathological and molecular study of 85 cases indicating GNA14 as the most commonly mutated gene in vascular neoplasms.
Liau JY; Lee JC; Tsai JH; Chen CC; Chung YC; Wang YH
Mod Pathol; 2019 Nov; 32(11):1657-1665. PubMed ID: 31189994
[TBL] [Abstract][Full Text] [Related]
3. GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.
Liau JY; Tsai JH; Lan J; Chen CC; Wang YH; Lee JC; Huang HY
Virchows Arch; 2020 Mar; 476(3):475-481. PubMed ID: 31707589
[TBL] [Abstract][Full Text] [Related]
4. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth.
Couto JA; Ayturk UM; Konczyk DJ; Goss JA; Huang AY; Hann S; Reeve JL; Liang MG; Bischoff J; Warman ML; Greene AK
Angiogenesis; 2017 Aug; 20(3):303-306. PubMed ID: 28120216
[TBL] [Abstract][Full Text] [Related]
5. Oral pyogenic granulomas show MAPK/ERK signaling pathway activation, which occurs independently of BRAF, KRAS, HRAS, NRAS, GNA11, and GNA14 mutations.
Pereira TDSF; de Amorim LSD; Pereira NB; Vitório JG; Duarte-Andrade FF; Guimarães LM; Diniz MG; Gomes CC; Gomez RS
J Oral Pathol Med; 2019 Nov; 48(10):906-910. PubMed ID: 31310691
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.
Boru G; Cebulla CM; Sample KM; Massengill JB; Davidorf FH; Abdel-Rahman MH
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2474-2480. PubMed ID: 31173078
[TBL] [Abstract][Full Text] [Related]
7. Genetic investigation of childhood vascular tumor biology reveals pathways for therapeutic intervention.
Cheraghlou S; Lim Y; Choate K
F1000Res; 2019; 8():. PubMed ID: 31069062
[TBL] [Abstract][Full Text] [Related]
8. Tufted angioma with associated Kasabach-Merritt phenomenon caused by somatic mutation in GNA14.
Lim YH; Fraile C; Antaya RJ; Choate KA
Pediatr Dermatol; 2019 Nov; 36(6):963-964. PubMed ID: 31423605
[TBL] [Abstract][Full Text] [Related]
9. Frequent GNAQ and GNA14 Mutations in Hepatic Small Vessel Neoplasm.
Joseph NM; Brunt EM; Marginean C; Nalbantoglu I; Snover DC; Thung SN; Yeh MM; Umetsu SE; Ferrell LD; Gill RM
Am J Surg Pathol; 2018 Sep; 42(9):1201-1207. PubMed ID: 29975248
[TBL] [Abstract][Full Text] [Related]
10. GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system.
Gessi M; Hammes J; Lauriola L; Dörner E; Kirfel J; Kristiansen G; zur Muehlen A; Denkhaus D; Waha A; Pietsch T
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):417-25. PubMed ID: 22758774
[TBL] [Abstract][Full Text] [Related]
11. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma.
Ayturk UM; Couto JA; Hann S; Mulliken JB; Williams KL; Huang AY; Fishman SJ; Boyd TK; Kozakewich HP; Bischoff J; Greene AK; Warman ML
Am J Hum Genet; 2016 Apr; 98(4):789-95. PubMed ID: 27058448
[TBL] [Abstract][Full Text] [Related]
12. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.
Küsters-Vandevelde HV; Klaasen A; Küsters B; Groenen PJ; van Engen-van Grunsven IA; van Dijk MR; Reifenberger G; Wesseling P; Blokx WA
Acta Neuropathol; 2010 Mar; 119(3):317-23. PubMed ID: 19936769
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression pattern, chromosomal localization, and evolution analysis of Porcine gnaq, gna11, and gna14.
Chen H; Yao W; Jin D; Xia T; Chen X; Lei T; Zhou L; Yang Z
Biochem Genet; 2008 Aug; 46(7-8):398-405. PubMed ID: 18330691
[TBL] [Abstract][Full Text] [Related]
14. Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.
Möller I; Murali R; Müller H; Wiesner T; Jackett LA; Scholz SL; Cosgarea I; van de Nes JA; Sucker A; Hillen U; Schilling B; Paschen A; Kutzner H; Rütten A; Böckers M; Scolyer RA; Schadendorf D; Griewank KG
Mod Pathol; 2017 Mar; 30(3):350-356. PubMed ID: 27934878
[TBL] [Abstract][Full Text] [Related]
15. Subcellular distribution patterns and elevated expression of GNA11 and GNA14 proteins in the lungs of humans with pulmonary arterial hypertension.
Lei W; Chen P; Yue Y; He Y; Shui X; Li G; Zhang L; Huang S; Chen C
Cell Biol Int; 2014 Sep; 38(9):1041-9. PubMed ID: 24797109
[TBL] [Abstract][Full Text] [Related]
16. Mutations in GNA11 in uveal melanoma.
Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
[TBL] [Abstract][Full Text] [Related]
17. Reverse Phenotyping in Patients with Skin Capillary Malformations and Mosaic GNAQ or GNA11 Mutations Defines a Clinical Spectrum with Genotype-Phenotype Correlation.
Jordan M; Carmignac V; Sorlin A; Kuentz P; Albuisson J; Borradori L; Bourrat E; Boute O; Bukvic N; Bursztejn AC; Chiaverini C; Delobel B; Fournet M; Martel J; Goldenberg A; Hadj-Rabia S; Mahé A; Maruani A; Mazereeuw J; Mignot C; Morice-Picard F; Moutard ML; Petit F; Pasteur J; Phan A; Whalen S; Willems M; Philippe C; Vabres P
J Invest Dermatol; 2020 May; 140(5):1106-1110.e2. PubMed ID: 31726051
[No Abstract] [Full Text] [Related]
18. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
19. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic Congenital Hemangioma and Congenital Hemangiomatosis Associated With a Somatic Activating Mutation in GNA11.
Funk T; Lim Y; Kulungowski AM; Prok L; Crombleholme TM; Choate K; Bruckner AL
JAMA Dermatol; 2016 Sep; 152(9):1015-20. PubMed ID: 27438697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
